{
    "id": "dbpedia_8098_1",
    "rank": 96,
    "data": {
        "url": "https://www.medicaldesignandoutsourcing.com/simcere-pharmaceutical-group-appoints-industry-veteran-mr-hong-zhao-as-executive-vice-president-of-sales-and-marketing/",
        "read_more_link": "",
        "language": "en",
        "title": "Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing",
        "top_image": "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2019/02/cropped-MDO_favicon_2-19-32x32.jpg",
        "meta_img": "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2019/02/cropped-MDO_favicon_2-19-32x32.jpg",
        "images": [
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2022/12/mdo-logo-white-treatment.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2016/02/Nitinol_draht.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2024/08/DeviceTalks-West-2024-268x170.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2024/08/MDO-Min-Vasive-Medtech-series-268x170.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2020/07/FDA-268x170.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2023/11/MDO.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2021/11/MDO-Nov-2021-cover-small.jpg",
            "https://images.designworldonline.com/newsletters/images/ee034d8d8274c1ee5e8111f11cf1be49.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2015/05/device-talks.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2018/01/visitsite-240x451.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2019/08/MedicalTubing-300x250.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2015/05/mass-device.jpg",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2018/01/visitsite-240x451.png",
            "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2019/05/MD_webAD_2019.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Bio-Medicine.Org"
        ],
        "publish_date": "2011-02-11T01:34:34+00:00",
        "summary": "",
        "meta_description": "NANJING, China, Feb. 11, 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (\"Simcere\" or the \"Company\") (NYSE: SCR), a leading pharmaceutical company",
        "meta_lang": "en",
        "meta_favicon": "https://www.medicaldesignandoutsourcing.com/wp-content/uploads/2019/02/cropped-MDO_favicon_2-19-32x32.jpg",
        "meta_site_name": "Medical Design and Outsourcing",
        "canonical_link": "https://www.medicaldesignandoutsourcing.com/simcere-pharmaceutical-group-appoints-industry-veteran-mr-hong-zhao-as-executive-vice-president-of-sales-and-marketing/",
        "text": "NANJING, China, Feb. 11, 2011 /PRNewswire-Asia/ — Simcere\n\nPharmaceutical Group (“Simcere” or the “Company”) (NYSE:\n\nSCR), a leading pharmaceutical company specializing in the\n\ndevelopment, manufacturing, and marketing of branded and\n\nproprietary pharmaceuticals in China, today announced the\n\nappointment of Mr. Hong Zhao, a highly regarded executive in the\n\nChinese pharmaceutical industry, as its executive vice president of\n\nsales and marketing, effective February 12, 2011.\n\n“Mr. Zhao is highly respected in the Chinese pharmaceutical\n\nindustry,” said Mr. Jinsheng Ren, Chairman and Chief Executive\n\nOfficer of Simcere. “Mr. Zhao has nearly 20 years’ experience in\n\nthe pharmaceutical industry with a proven track record of\n\nleadership and performance. We warmly welcome Mr. Zhao who\n\nwill help strengthen our leadership team and better position our\n\nbusiness for sustainable growth.”\n\nMr. Zhao commented, “I am delighted to be joining Simcere, an\n\nenergetic and promising company that I have long admired for its\n\nvalue and vision. I am looking forward to working with such an\n\ninnovative team to enhance the competitiveness of Simcere and help\n\nmake a difference to the healthcare industry in China.”\n\nMr. Hong Zhao joined the industry in 1992. He started as a\n\npharmaceutical sales representative and took on positions of\n\nincreasing responsibilities in sales & marketing with Xian\n\nJanssen and Novartis China. He most recently held the position of\n\nSenior Vice President of Novartis Greater China and General Manager\n\nof Novartis Shanghai. Mr. Zhao received an EMBA degree from China\n\nEurope International Business School (CEIBS), and a bachelor’s\n\ndegree in Medicine from Nanjing Medical University.\n\nAbout Simcere Pharmaceutical GroupSimcere Pharmaceutical\n\nGroup (NYSE: SCR, Simcere) is a leading pharmaceutical company\n\nspecializing in the development, manufacturing, and marketing of\n\nbrand\n\n‘/>”/>"
    }
}